HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Braun Selected Research

Rheumatic Diseases (Rheumatism)

11/2021[Are SARS-CoV-2 reactive T cells detectable and potentially protective in patients under anti-CD20 treatment with an impaired humoral response?]
10/2021[Lay version of the 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis : Translation into German and linguistic validation in German-speaking countries with people affected].
2/2021[Threat of a SARS-CoV-2 endemic in a large hospital specialized in rheumatic diseases-relative all clear through consistent testing].
3/2017The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.
3/2016European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.
11/2014[Implementation and use of biosimilars in the therapy of inflammatory rheumatic diseases: Statement of the German Society of Rheumatology].
4/2012Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.
2/2012[Practical problems by implementation of vaccination recommendations].
1/2012European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies.
9/2011Low-dose glucocorticoids in rheumatic diseases: introduction.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Braun Research Topics

Disease

84Ankylosing Spondylitis
02/2020 - 02/2000
36Necrosis
03/2016 - 04/2000
24Rheumatoid Arthritis
10/2021 - 04/2000
23Arthritis (Polyarthritis)
02/2020 - 01/2000
23Inflammation (Inflammations)
03/2017 - 01/2000
20Rheumatic Diseases (Rheumatism)
11/2021 - 09/2002
17Axial Spondyloarthritis
02/2020 - 07/2012
14Back Pain (Backache)
01/2022 - 01/2000
12Psoriatic Arthritis
03/2016 - 02/2000
11Pain (Aches)
10/2019 - 09/2000
11Sacroiliitis
08/2019 - 01/2000
10Osteoporosis
11/2011 - 04/2001
9Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2016 - 07/2000
8Spondylarthropathies
03/2005 - 04/2000
7Neoplasms (Cancer)
02/2020 - 07/2009
7Infections
02/2012 - 09/2000
6Anterior Uveitis
09/2014 - 03/2001
6Ankylosis
09/2008 - 01/2000
5Psoriasis (Pustulosis Palmaris et Plantaris)
01/2016 - 05/2004
5Crohn Disease (Crohn's Disease)
05/2007 - 01/2000
5Ulcerative Colitis
05/2007 - 01/2000
5Reactive Arthritis (Reiter Disease)
09/2002 - 01/2000
4Non-Radiographic Axial Spondyloarthritis
02/2020 - 07/2010
4Pneumonia (Pneumonitis)
01/2006 - 06/2000
3Spondylitis
09/2014 - 07/2003
3Hemorrhage
01/2012 - 02/2007
3Wounds and Injuries (Trauma)
12/2011 - 02/2007
3Body Weight (Weight, Body)
05/2004 - 04/2003
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2002 - 03/2000
2Measles
11/2020 - 11/2020
2Spondylarthritis (Spinal Arthritis)
02/2020 - 06/2003
2Endometrial Neoplasms (Endometrial Cancer)
10/2017 - 11/2013
2Gout
03/2017 - 01/2017
2Atrial Fibrillation
02/2016 - 01/2012
2Liver Cirrhosis (Hepatic Cirrhosis)
11/2012 - 08/2012
2Sarcoidosis (Schaumann Disease)
09/2010 - 06/2001
2Myositis (Idiopathic Inflammatory Myopathies)
09/2010 - 01/2002
2Spinal Diseases (Disease, Spinal)
04/2008 - 09/2004
2Joint Diseases (Joint Disease)
01/2007 - 06/2004
2Chronic Disease (Chronic Diseases)
11/2006 - 06/2001

Drug/Important Bio-Agent (IBA)

36Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2013 - 04/2000
32Infliximab (Remicade)FDA Link
02/2020 - 06/2000
17Etanercept (Enbrel)FDA Link
05/2011 - 07/2001
14Biological ProductsIBA
02/2020 - 07/2001
13Methotrexate (Mexate)FDA LinkGeneric
03/2017 - 04/2000
13CytokinesIBA
06/2006 - 04/2000
12Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2020 - 01/2000
12Proteins (Proteins, Gene)FDA Link
10/2017 - 03/2000
10Antirheumatic Agents (DMARD)IBA
02/2020 - 11/2002
10O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
12/2014 - 01/2000
9Monoclonal AntibodiesIBA
11/2021 - 06/2000
9AntibodiesIBA
11/2020 - 01/2000
9Sulfasalazine (Azulfidine)FDA LinkGeneric
12/2013 - 01/2002
8HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2022 - 04/2000
8GlucocorticoidsIBA
02/2020 - 04/2001
8Tumor Necrosis Factor InhibitorsIBA
02/2020 - 09/2004
8Pharmaceutical PreparationsIBA
02/2020 - 09/2000
8C-Reactive ProteinIBA
01/2015 - 06/2003
7AntigensIBA
01/2015 - 01/2000
7Adrenal Cortex Hormones (Corticosteroids)IBA
12/2013 - 04/2001
7Interleukin-10 (Interleukin 10)IBA
06/2006 - 04/2000
5InterleukinsIBA
02/2020 - 06/2001
5Anti-Bacterial Agents (Antibiotics)IBA
01/2017 - 04/2000
5SteroidsIBA
09/2011 - 04/2001
5Interferon-gamma (Interferon, gamma)IBA
06/2006 - 04/2000
4Immunoglobulin G (IgG)IBA
11/2020 - 11/2013
4Adalimumab (Humira)FDA Link
08/2013 - 05/2005
4Vitamin DFDA LinkGeneric
11/2011 - 03/2000
4Diphosphonates (Bisphosphonates)IBA
11/2011 - 07/2001
4Biomarkers (Surrogate Marker)IBA
02/2009 - 02/2000
4Gadolinium DTPA (Magnevist)FDA Link
05/2005 - 02/2000
4Interleukin-4 (Interleukin 4)IBA
07/2003 - 04/2000
3Biosimilar PharmaceuticalsIBA
03/2017 - 11/2014
3Certolizumab PegolFDA Link
03/2015 - 01/2014
3Prednisolone (Predate)FDA LinkGeneric
01/2014 - 01/2002
3Indicators and Reagents (Reagents)IBA
01/2012 - 01/2000
3GadoliniumIBA
04/2008 - 09/2002
3Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2005 - 02/2001
3Contrast MediaIBA
11/2002 - 12/2000
3AutoantibodiesIBA
01/2002 - 03/2000
3EnzymesIBA
04/2001 - 07/2000
3EpitopesIBA
03/2000 - 02/2000
2Rituximab (Mabthera)FDA Link
11/2021 - 05/2010
2Antinuclear AntibodiesIBA
10/2020 - 01/2002
2secukinumabIBA
02/2020 - 01/2019
2MicroRNAs (MicroRNA)IBA
11/2018 - 07/2010
2Uric Acid (Urate)IBA
03/2017 - 01/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2013 - 09/2008
2Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2013 - 01/2002
2Antiviral Agents (Antivirals)IBA
11/2012 - 11/2011
2CalciumIBA
11/2011 - 06/2010
2Messenger RNA (mRNA)IBA
09/2008 - 06/2001
2Interleukin-6 (Interleukin 6)IBA
04/2008 - 06/2006
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
08/2006 - 02/2001

Therapy/Procedure

73Therapeutics
10/2019 - 04/2000
5Biological Therapy
01/2016 - 09/2003
3Drug Therapy (Chemotherapy)
12/2014 - 06/2000
2Injections
12/2013 - 02/2007
2Operative Surgical Procedures
01/2011 - 09/2010
2Aftercare (After-Treatment)
04/2008 - 04/2005